Close
Nordic 9Nordic 9

Hybio Pharamaceutical (investor - Corporate Investor)

See something wrong or missing? Let us know
Offices:Shenzen

Hybio Pharmaceuticals is a leading high-tech pharmaceutical company listed on the Shenzhen stock exchange with a market capitalization of c. NOK 16 billion. The company was founded in 1998 with a focus on research, development and manufacturing of peptide products, including several for the diabetes market. Hybio is headquartered in Shenzhen

Average round investment:2.37M USD
Average number per year:1.0
Distribution: 2015 (1)
Portfolio companies: Norway Prediktor
Mostly invests in: Norway Norway (1) Hardware (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Hybio Pharamaceutical

Name Criteria
Norway Frode Foss
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Hardware, Manufacturing, Wearable
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
Norway Håkon Sagberg
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Hardware, Manufacturing, Wearable
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
Norway Karl-Axel Hjorth Bauer
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Hardware, Manufacturing, Wearable
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
Norway Knut Sandven
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Hardware, Manufacturing, Wearable
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
Norway Morgan Kjølerbakken
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Hardware, Manufacturing, Wearable
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
Norway Nadir Nalbant
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Hardware, Manufacturing, Wearable
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
Norway Northscaler
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Wearable
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
Norway Ole-Herman Bjor
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Hardware, Manufacturing, Wearable
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
Norway Ralph W. Bernstein
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Hardware, Manufacturing, Wearable
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
Norway TTC Invest
79%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Wearable
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
Top